LENZ Therapeutics, Inc. Common Stock
XNAS:LENZ
30.52
$31.15 - 550.00
$28.88 - 15.00
$30.19
$31.58
$30.72
$30.72
50.4
16.54
117190
873820.2
27863807.58
Chart
TendieTensor AI Analysis
Company
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.
Fundamentals
42
-14.480000
4.499190
-0.59
100
BBG00XDH4NZ2
BBG00XDH4P05
28.52M
31.29M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own LENZ. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.